Logo
A

Atlas Venture

101 employees

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Investor insights

Countries invested in

germany1

Sectors invested in

Biotechnology142
Health Care104
Software94
Therapeutics79
Medical49
Pharmaceutical44
Mobile44
Analytics36
Enterprise Software33
Biopharma30
Big Data27
SaaS26
Internet23
E-Commerce21
Security20
Telecommunications20
Semiconductor19
Hardware18
Video18
Advertising17

Funding rounds participated in

$18M sweet spot round size

Most of their 521 investments are in rounds between $5.1M and $25M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Pharmaceutical
Health Care
Venture Capital
Biotech and Venture Capital

Date founded

1984

Investments made

U

Undisclosed raised $210M on September 6, 2023

Investors: GV, RA Capital Management, L.P., Lightstone Ventures, S.R. One Ltd and Atlas Venture

K

K36 Therapeutics, Inc. raised $70M on June 28, 2023

Investors: Nextech Invest, Bristol-Myers Squibb, UK, F-Prime Capital Partners and Atlas Venture

P

Pheon Therapeutics raised $68M on September 28, 2022

Investors: Research Corporation Technologies, Inc., Forbion, Brandon Capital Partners and Atlas Venture

U

Undisclosed raised $125M on September 12, 2022

Investors: SV Life Sciences, S.R. One Ltd, Lightstone Ventures, RA Capital Management, L.P. and Atlas Venture

D

Disc Medicine raised $54M on August 10, 2022

Investors: OrbiMed Advisors, Novo Holdings, 5AM Ventures, Arix Bioscience plc and Atlas Venture

R

Remix Therapeutics raised $70M on May 17, 2022

Investors: The Column Group, Foresite Capital, Surveyor Capital, ARCH Venture Partners, Casdin Capital, LLC and Atlas Venture

S

Sionna Therapeutics raised $110M on April 19, 2022

Investors: OrbiMed Advisors, RA Capital Management, L.P., T. Rowe Price and Atlas Venture

B

Be Biopharma raised $130M on April 14, 2022

Investors: Alta Partners, Takeda UK Limited, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, RA Capital Management, L.P. and Atlas Venture

T

TRIANA Biomedicines raised $110M on April 6, 2022

Investors: Logos Global Management, LP, Surveyor Capital, Lightspeed Venture Partners, RA Capital Management, L.P. and Atlas Venture

A

Arkuda Therapeutics raised $64M on February 10, 2022

Investors: Surveyor Capital, Mission BioCapital, Tekla Capital Management and Atlas Venture

FAQ